Jeffrey A Meckler
Director at Travere Therapeutics, Inc. (TVTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 11SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,700109,800 held (−2%) | $65.39 | $111K | -20.3% |
| Sep 11SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,200108,600 held (−1%) | $66.15 | $79K | -21.2% |
| Sep 11SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 14,00094,600 held (−13%) | $67.46 | $944K | -22.7% |
| Sep 11SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 3,10091,500 held (−3%) | $68.09 | $211K | -23.4% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 8,00087,500 held (−8%) | $45.00 | $360K | +15.8% |
- Sell
Director Jeffrey A Meckler sold $111K of TVTX at $65.39 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey A Meckler sold $79K of TVTX at $66.15 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey A Meckler sold $944K of TVTX at $67.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey A Meckler sold $211K of TVTX at $68.09 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey A Meckler sold $360K of TVTX at $45.00 — pre-scheduled 10b5-1 plan sale.